Topic
BCG-Unresponsive Bladder Cancer
6 Podcasts • 1 Course on BackTable
Hear how experienced physicians manage BCG-Unresponsive Bladder Cancer on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 320 • 31 Jul 2026
Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive
Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Ruchi Talwar interviews Dr. Sarah Psutka to explore the emerging role of a novel intravesical device that delivers sustained gemcitabine therapy for patients refusing or ineligible for cystectomy. They highlight new FDA-approved treatment options, real-world workflow considerations, and the clinical potential for continuous intravesical chemotherapy in a crowded therapeutic landscape.
This podcast is supported by
More on BCG-Unresponsive Bladder Cancer
Loading recent podcasts…
Urology # 320
Jul 30, 2026
with Dr. Sarah Psutka, Dr. Ruchika Talwar
Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder...
1,000+ listens
Urology # 268
Oct 23, 2025
with Dr. Tyler Stewart, Dr. Bogdana Schmidt
With the introduction of checkpoint inhibitors into non-muscle invasive bladder cancer (NMIBC) management, who’s on...
1,200+ listens
Tumor Board # 27
Oct 6, 2025
with Dr. Tyler Stewart, Dr. Bogdana Schmidt
With the introduction of checkpoint inhibitors into non-muscle invasive bladder cancer (NMIBC) management, who’s on...
Urology # 305
Jun 1, 2026
with Dr. Sam Chang, Dr. Ruchika Talwar
Ready to move beyond “one-size-fits-all” for BCG-unresponsive NMIBC? In this episode of BackTable Urology, Dr. Ruchika...
1,300+ listens
Urology # 267
Oct 20, 2025
with Dr. Mark Tyson, Dr. Suzanne Merrill, Dr. Bogdana Schmidt
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the...
1,400+ listens
Tumor Board # 26
Oct 6, 2025
with Dr. Mark Tyson, Dr. Suzanne Merrill, Dr. Bogdana Schmidt
New FDA-approved therapies for BCG-refractory non-muscle invasive bladder cancer (NMIBC)–where do they fit in the...
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.